Previous 10 | Next 10 |
VANCOUVER, British Columbia, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Siyata Mobile Inc. ( Nasdaq: SYTA, SYTAW ) (“Siyata” or the “Company”), a leading global developer and provider of cellular communications solutions for enterprise customers, today...
Ashford (AINC) +75%.PEDEVCO (PED) +62%.SGOCO (SGOC) +49%.Ebang International Holdings (EBON) +33%.Red Lion Hotels RLH +31% on being acquired by Sonesta.Canaan (CAN) +30%.AirNet Technology (ANTE) +25%.Hudson Capital HUSN +24% as FreightHub posts stellar Q3 results.Hoth Ther...
Aiming to accelerate the clinical development of S-layer nanotechnology for mucosal vaccines, hemo-filtration devices, cell-based therapies and other medical applications Establishing state-of-the-art research facility at the University of Natural Resources and Life Sciences (BOKU) in...
Are These 3 Penny Stocks On Your Watch List Right Now? Something almost all traders look for when it comes to trading penny stocks is a catalyst. They like to know the reason why certain stocks are moving the way they are. This might be a sector-related catalyst. It might also be a ...
Avalon GloboCare (AVCO) +38.5% PM, and Adial Pharmaceuticals (ADIL) +34.5% PM, formed a strategic collaboration for global distribution of the Assure/Fastep COVID-19 IgG/IgM Rapid Test device and the Assure/EcoStep COVID-19 IgG/IgM Rapid Test device, point-of-care COVID-19 ant...
FREEHOLD, N.J. and CHARLOTTESVILLE, Va., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO ) (“A valon ”) , a clinical-stage, global developer of cell-based technologies and therapeutics and Adial Pharmaceuticals, Inc. (NASDAQ...
After the completion of Phase I first-in-human study of Avalon GloboCare's ([[AVCO]] -3.2%) lead CAR T-cell therapy, AVA-001, the company is in the process of advancing the therapy to the next phase of clinical development. Announced to expand patient enrollment for AVA-001 trial, a...
Expanded AVA-001 CAR T- cell therapy clinical trial to include enrollment of patients with relapsed/refractory non-Hodgkin lymphoma Completed pre-clinical study and standardized process development for innovative allogeneic MSC-based...
Gainers: CTI BioPharma (CTIC) +99%, Genetron Holdings (GTH) +26%, Allena Pharmaceuticals (ALNA) +23%, Neurotrope (NTRP) +20%, Kaleido Biosciences (KLDO) +11%.Losers: Aptorum Group (APM) -41%, Adial Pharmaceuticals (ADIL) -21%, Avalon...
Aptorum Group (APM) -35% after pricing share and warrant offering.Adial Pharmaceuticals (ADIL) -23%.FuelCell Energy (FCEL) -14% after pricing equity offering.PEDEVCO (PED) -12%.Urban One (UONE) -12%.Greenpro Capital (GRNQ) -12%.Piedmont Lithium (PLL) -9%.Westwater Resource...
News, Short Squeeze, Breakout and More Instantly...
Avalon GloboCare Corp. Company Name:
AVCO Stock Symbol:
NASDAQ Market:
Company to Begin Trading under New Symbol “ALBT” on November 10, 2022 Symbol Change Better Reflects Avalon’s New Focus on Laboratory Services and Biotherapeutics FREEHOLD, N.J., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon...
Company to acquire a majority interest in Laboratory Services MSO, LLC, a leading reference laboratory with 2021 unaudited revenue in excess of $25 million, net income in excess of $10 million and over 600,000 tests completed since inception Cash portion to be financed with a ...
Freehold, New Jersey--(Newsfile Corp. - October 19, 2022) - Avalon GloboCare Corp. (NASDAQ: AVCO) , a leading global developer of innovative cell-based technologies and therapeutics, announced today that David Jin, M.D., Ph.D., President and Chief Executive Officer, and Luisa Ingargiola, Ch...